CVS Health Co. (NYSE:CVS) Stock Holdings Boosted by Community Trust & Investment Co.

Community Trust & Investment Co. lifted its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 14.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 265,953 shares of the pharmacy operator's stock after acquiring an additional 33,457 shares during the quarter. CVS Health accounts for 1.2% of Community Trust & Investment Co.'s portfolio, making the stock its 29th largest holding. Community Trust & Investment Co.'s holdings in CVS Health were worth $18,018,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Hopwood Financial Services Inc. bought a new stake in shares of CVS Health during the 4th quarter worth $29,000. McIlrath & Eck LLC boosted its stake in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 174 shares in the last quarter. Financial Perspectives Inc boosted its stake in shares of CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after acquiring an additional 466 shares in the last quarter. Compass Planning Associates Inc bought a new stake in shares of CVS Health during the 4th quarter worth $37,000. Finally, Providence First Trust Co bought a new stake in shares of CVS Health during the 4th quarter worth $42,000. 80.66% of the stock is owned by institutional investors.

CVS Health Trading Up 1.6%

CVS Health stock opened at $67.42 on Monday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The company has a market capitalization of $85.29 billion, a price-to-earnings ratio of 18.42, a PEG ratio of 0.98 and a beta of 0.56. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51. The company's fifty day moving average price is $65.15 and its two-hundred day moving average price is $60.15.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business's quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.31 earnings per share. On average, analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were paid a $0.665 dividend. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.95%. CVS Health's payout ratio is presently 63.48%.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. JPMorgan Chase & Co. increased their target price on CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a report on Tuesday, February 18th. Piper Sandler increased their target price on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a report on Friday, March 21st. Morgan Stanley restated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Finally, Royal Bank of Canada increased their target price on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a report on Monday, May 5th. Two research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $74.75.

Insider Buying and Selling

In other news, Director Guy P. Sansone bought 1,570 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The shares were acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the transaction, the director now directly owns 12,007 shares in the company, valued at $764,845.90. This represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.22% of the stock is owned by company insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.